{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"producer": "iLovePDF", "creator": "PDFMiner", "creationdate": "", "moddate": "2025-09-14T06:45:35+00:00", "total_pages": 280, "source": "./oasis_manual.pdf"}, "page_content": "\u00ad  Patient\u2019s list of medications from the inpatient facility discharge instructions DO NOT match the \n\nmedications the patient shows the clinician at the SOC/ROC assessment visit. \n\n\u00ad  Assessment shows that diagnoses/symptoms for which the patient is taking medications are NOT \n\nadequately controlled. \n\n\u00ad  Patient seems confused about when/how to take medications indicating a high risk for medication \n\nerrors. \n\n\u00ad  Patient has not obtained medications or indicates that they will not take prescribed medications because \n\nof financial, access, cultural, or other issues with medications. \n\n\u00ad  Patient has signs/symptoms that could be adverse reactions from medications. \n\u00ad  Patient takes multiple non-prescribed medications (OTCs, herbals) that could interact with prescribed \n\nmedications. \n\n\u00ad  Patient has a complex medication plan with medications prescribed by multiple physicians and/or \n\nobtained from multiple pharmacies so that the risk of drug interactions is high. \n\n\u2022  Code 9, NA- Patient is not taking any medications, if a drug regimen review was conducted at the time of \nthe patient\u2019s SOC/ROC and, per data sources/resources reviewed, there were no medications prescribed for \nthe patient and the patient was not taking any medications, by any route, at the time of the assessment. \n\n\u2022  Dash is a valid response for this item. \n\no  A dash indicates \u201cno information.\u201d CMS expects dash use to be a rare occurrence. \no  If elements of the drug regimen review were skipped, (for example drug-to-drug interactions were not \ncompleted), a dash (\u2013) should be reported, indicating the drug regimen review was not completed. \n\nCoding Tips \n\n\u2022  The drug regimen review is part of the comprehensive patient assessment. The comprehensive patient", "type": "Document"}}